1. Home
  2. STXS vs FLC Comparison

STXS vs FLC Comparison

Compare STXS & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • FLC
  • Stock Information
  • Founded
  • STXS 1990
  • FLC 2003
  • Country
  • STXS United States
  • FLC United States
  • Employees
  • STXS N/A
  • FLC N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FLC Trusts Except Educational Religious and Charitable
  • Sector
  • STXS Health Care
  • FLC Finance
  • Exchange
  • STXS Nasdaq
  • FLC Nasdaq
  • Market Cap
  • STXS 189.8M
  • FLC 180.6M
  • IPO Year
  • STXS 2004
  • FLC N/A
  • Fundamental
  • Price
  • STXS $2.08
  • FLC $16.70
  • Analyst Decision
  • STXS Strong Buy
  • FLC
  • Analyst Count
  • STXS 2
  • FLC 0
  • Target Price
  • STXS $4.50
  • FLC N/A
  • AVG Volume (30 Days)
  • STXS 422.5K
  • FLC 37.8K
  • Earning Date
  • STXS 03-03-2025
  • FLC 01-01-0001
  • Dividend Yield
  • STXS N/A
  • FLC 6.64%
  • EPS Growth
  • STXS N/A
  • FLC N/A
  • EPS
  • STXS N/A
  • FLC N/A
  • Revenue
  • STXS $25,143,000.00
  • FLC N/A
  • Revenue This Year
  • STXS $1.16
  • FLC N/A
  • Revenue Next Year
  • STXS $55.65
  • FLC N/A
  • P/E Ratio
  • STXS N/A
  • FLC N/A
  • Revenue Growth
  • STXS N/A
  • FLC N/A
  • 52 Week Low
  • STXS $1.66
  • FLC $12.62
  • 52 Week High
  • STXS $3.29
  • FLC $15.45
  • Technical
  • Relative Strength Index (RSI)
  • STXS 42.68
  • FLC 48.16
  • Support Level
  • STXS $2.21
  • FLC $16.56
  • Resistance Level
  • STXS $2.72
  • FLC $16.89
  • Average True Range (ATR)
  • STXS 0.16
  • FLC 0.22
  • MACD
  • STXS -0.04
  • FLC 0.01
  • Stochastic Oscillator
  • STXS 7.54
  • FLC 58.00

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.

About FLC Flaherty & Crumrine Total Return Fund Inc

Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.

Share on Social Networks: